Hi there,
I don't think there was an attachment. Would you mind resending?
Thanks,
Hayley
-----Original Message-----
From: Sopo Belkania [mailto:sbelkania@moh.gov.ge]
Sent: Friday, April 13, 2018 3:39 PM
To: Hayley Home
Subject: Re: Contact for Georgia Stop C Campaign
Sent from my iPhone
> On Apr 13, 2018, at 23:18, Hayley Home wrote:
>
> Hi Sopo,
> Is there any way you can share a high res version of the photo with us? It's showing up a bit grainy. Thank you!
>
> -----Original Message-----
> From: Graeme Robertson
> Sent: Wednesday, April 11, 2018 4:16 AM
> To: Sopo Belkania
> Cc: Hayley Home
> Subject: Re: Contact for Georgia Stop C Campaign
>
> Thank you so much Sopo for your quick and positive reply Best wishes
> Graeme
>
> Sent from my iPhone
>
>> On 11 Apr 2018, at 12:59, Sopo Belkania wrote:
>>
>> Dear Graeme,
>>
>> You can use photo below for a story.
>>
>> BR
>>
>> Sopo
>>
>> Sent from my iPhone
>>
>>> On Apr 10, 2018, at 23:32, Graeme Robertson wrote:
>>>
>>> Dear Sopo
>>>
>>> Please can you see the request from my colleague, would we be able to get your permission to use the photo below for a story on our website.
>>>
>>> Thank you for your consideration
>>> Best wishes
>>> Graeme
>>>
>>> Sent from my iPhone
>>>
>>> On 10 Apr 2018, at 21:48, Hayley Home > wrote:
>>>
>>> Hi Graeme,
>>> Hope all is well! Quick question – we’re updating the website with a
>>> story on HCV elimination and need a carousel image. Do you have a
>>> contact for the Stop C campaign? We’d like to use/get permission to
>>> use the photo here: http://agenda.ge/news/38606/eng
>>>
>>> Thanks!
>>> Hayley
>>> >> =
>>> images&cd=&ved=2ahUKEwjIqLSOmrDaAhXizVQKHaNLCIsQjRx6BAgAEAU&url=http
>>> %
>>> 3A%2F%2Fagenda.ge%2Fnews%2F38606%2Feng&psig=AOvVaw2maehgMksM0kjam5XA
>>> s Ru1&ust=1523466760959492> Hayley Home | Public Affairs | Gilead
>>> Sciences, Inc. | 333 Lakeside Drive | Foster City, CA 94404 | Phone:
>>> +1 650.377.3449 | Mobile: +1 916.402.2864
>>>
>>>
>>> This e-mail contains information that may be confidential. If you are not the intended recipient, please delete the e-mail and notify the sender at Kite Pharma immediately.
>>> DISCLAIMER If you have received this message in error, please
>>> contact the sender immediately by return e-mail and notify the
>>> sender and then delete this message (including any attachments) from
>>> your system. This communication and any attachments contain
>>> information which is confidential and may also be legally
>>> privileged. It is for the exclusive use of the intended
>>> recipient(s). If you are not the intended recipient(s) please note
>>> that any form of disclosure, distribution, copying or use of this
>>> communication or the information in it or in any attachments is
>>> strictly prohibited and may be unlawful. E-mail communications
>>> cannot be guaranteed to be secure or error free, as information
>>> could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses.
>>> Gilead does not accept liability for any such matters or their
>>> consequences. Anyone who communicates with Gilead by e-mail is taken
>>> to accept the risks in doing so. Gilead has taken every reasonable
>>> precaution to ensure that any attachment to this e-mail has been
>>> swept for viruses. However, Gilead cannot accept liability for any
>>> damage sustained as a result of viruses and would advise that you
>>> carry out your own virus checks before opening any attachment.
>>> Gilead Sciences Europe Ltd ; Registered as a limited company in
>>> England and Wales ; Registered number 5510315 Registered office:
>>> South Building ;
>>> 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England